Abstract
6-diazo-5-oxo-l-norleucine (DON) is a glutamine antagonist produced naturally by Streptomyces. It inhibits several glutamine-dependent enzyme pathways. Of particular note is its inhibitory effect on the mitochondrial enzyme, glutaminase (GLS), the primary producer of neuronal glutamate. Glutamate is an excitatory neurotransmitter released by primary sensory peripheral nerve terminals and spinal synaptic terminals during pain signaling. Previous work using the tail incision and inflammatory models of pain has demonstrated that a single application of the glutaminase inhibitor, DON, into a surgical incision or the paw of arthritic animals results in pain relief. Even though this compound shows promise as a therapeutic agent, limited data exist regarding its dermal toxicity. As a first approach, we evaluated the effect of several concentrations of DON, on the viability, mitochondrial oxidative capacity and proliferation of rat skin fibroblasts, and then examined the effect of DON after incubation with human liver microsomes on proliferation. Finally, we evaluated DON treated rat skin (tail and hind paw) for cellular necrosis, inflammation and mitotic bodies. No significant effects (p > 0.05) of DON were noted on apoptosis, necrosi...Continue Reading
References
Jan 1, 1990·Pharmacology & Therapeutics·G S AhluwaliaD A Cooney
Jan 2, 1989·Brain Research·H F BradfordP Foley
Jan 1, 1988·Cancer Chemotherapy and Pharmacology·M P SullivanB Van Nguyen
Aug 1, 1995·British Journal of Anaesthesia·C J Woolf
Sep 17, 1993·Neuroscience Letters·K E MillerT Kaneko
Apr 18, 1997·European Journal of Pharmacology·N B LawandK N Westlund
Nov 14, 1997·Neuroscience and Biobehavioral Reviews·J H McDonough, T M Shih
Aug 24, 1999·Cell Death and Differentiation·P WaringJ Beaver
Mar 29, 2000·The Journal of Nutrition·Y Daikhin, M Yudkoff
Jun 19, 2001·Journal of Immunological Methods·L J JonesV L Singer
Nov 1, 1957·Cancer·G B MAGILLJ H BURCHENAL
Feb 19, 2004·Archives of Physical Medicine and Rehabilitation·William W TsangChristina W Hui-Chan
Mar 19, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rita BardoniAmy B MacDermott
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
Apr 16, 2008·Journal of Cellular and Molecular Medicine·A ScharstuhlF A D T G Wagener
Apr 17, 2008·Biological cybernetics·Janneke F M Jehee, Jaap M J Murre
Jan 1, 2007·Toxicology Mechanisms and Methods·Afshin Mohammadi-Bardbori, Mahmoud Ghazi-Khansari
Oct 20, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Gang Niu, Xiaoyuan Chen
Nov 3, 2010·The Journal of Clinical Investigation·Adrienne E Dubin, Ardem Patapoutian
Feb 1, 2011·Pharmacology & Therapeutics·Kenneth E MillerRuben Schechter
Mar 10, 2011·PloS One·Jon Halvor Jonsrud KnutsenErik Boye
Feb 14, 2012·Current Pain and Headache Reports·Dan Levy
Apr 10, 2013·Trends in Cell Biology·Hirofumi HarashimaArp Schnittger
Oct 13, 2015·Journal of Pain & Palliative Care Pharmacotherapy·Frank Brennan
Jan 1, 2015·MOJ Toxicology·Heith A CrosbyKenneth E Miller
Citations
Jan 1, 2015·MOJ Toxicology·Heith A CrosbyKenneth E Miller
Sep 25, 2015·International Journal of Molecular Sciences·Lian Chen, Hengmin Cui
May 30, 2017·Toxicology Mechanisms and Methods·Rohan M KulkarniPramod S Terse
Jul 7, 2018·Journal of Neuroinflammation·Di MaJiachun Feng
Jun 19, 2019·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Michael T NedelcovychBarbara S Slusher
Jun 3, 2021·International Journal of Molecular Sciences·Hyeon Young ParkKeun-Gyu Park